Prognostic Analysis of ERCC1, RRM1 and p53 Expressions in Postoperative Stage Ⅰ-Ⅱ Lung Cancer

Prognostic Analysis of ERCC1, RRM1 and p53 Expressions in Postoperative Stage Ⅰ-Ⅱ Lung Cancer

Background and objective Cisplatin is an important drug in lung cancer chemotherapy. It has been proven that ERCC1, RRM1, p53 expressions were related to resistance to platinum and prognosis of the patcents with lung cancer. The aim of this study is to analyze the association of the expression of ER...

Full description

Bibliographic Details
Main Authors: Baohui HAN, Huifang SHA, Xiaohua YANG, Weizhong HE, Xueyan ZHANG, Huimin WANG, Jiuxian FENG
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2009-05-01
Series:Chinese Journal of Lung Cancer
Subjects:
Human ERCC1 protein
Human RRM1 protein
Tumor suppressor protein p53
Lung neoplasms
Prognosis
Drug resistance
Online Access:http://www.lungca.org/index.php?journal=01&page=article&op=view&path%5B%5D=10.3779%2Fj.issn.1009-3419.2009.05.003&path%5B%5D=817

Internet

http://www.lungca.org/index.php?journal=01&page=article&op=view&path%5B%5D=10.3779%2Fj.issn.1009-3419.2009.05.003&path%5B%5D=817

Similar Items